From 10 to 12 June 2026, the Palacongressi di Rimini will host the 65th AFI Symposium. Within the programme, the pharmacovigilance session will be dedicated to the evolution of Important Safety Communications, a topic that highlights the importance of coordinated processes, controlled timelines and traceable activities. The SafetyDrugs team will attend the event with a new solution dedicated to the management of regulatory deadlines.
The AFI Symposium 2026 and the evolution of the healthcare industry
From 10 to 12 June 2026, the Palacongressi di Rimini will host the 65th AFI Symposium, dedicated to the theme The Healthcare Industry in the Age of Artificial Intelligence. The 2026 edition will focus on the role of artificial intelligence and new technologies in the transformation of the healthcare industry, with a cross-functional view of the medicinal product lifecycle and the processes that support quality, innovation and compliance. The programme reflects this approach through a broad agenda, with sessions dedicated to clinical research, regulatory, digital health, quality and market access.
The pharmacovigilance session: when and where to attend
Within this framework, Session III – Pharmacovigilance will take place on Wednesday, 10 June 2026, from 15:15 to 18:30, in the Castello Room. The session will be dedicated to the evolution of Important Safety Communications and will bring together multiple perspectives: regulatory authorities, healthcare professionals, patient associations, pharmaceutical companies and industry representatives.
For those working in pharmacovigilance, regulatory affairs, quality or information systems, the session offers a concrete opportunity to observe how safety information is assessed, organised and communicated to the relevant stakeholders. The topic also recalls key operational aspects: cross-functional coordination, compliance with timelines, traceability of activities and alignment with regulatory requirements.
Max Application at the AFI Symposium 2026: find out Chronisia
The Max Application team will be present at the AFI Symposium 2026 in the exhibition area, at stand 60. It will be an opportunity to learn more about the SafetyDrugs FDA Submission functionality for the submission of ICSRs in ICH E2B(R3) format and to discover Chronisia, the new product dedicated to the management of pharmaceutical regulatory deadlines.
Chronisia was developed to help Pharmacovigilance and Regulatory Affairs teams plan, monitor and meet the required deadlines. The solution makes it possible to:
- automatically calculate submission dates for Periodic Safety Reports and Marketing Authorization Renewal, as well as other scenarios;
- turn deadlines into operational activities, with assignees, dates, progress statuses and notifications, while monitoring work through dashboards and exportable reports;
- maintain evidence of the actions performed through audit trail, notes and contextual comments, supporting process traceability in case of audits or inspections.
We look forward to seeing you at stand 60 to learn more and schedule a live demo of Chronisia.
